Eu2P

Description

Objectives To identify the key roles, routes and tools of communication on medicines and their risks To know the evolution of medicines risk communication and overview of the regulatory responsibilities and requirement To be aware of environmental drug impact communication Topics covered: Principal actors in communication on medicines risk, of traditional and new forms of communication, of routes of communication and their evolution through time Basis of risk communication process Regulatory Responsibilities and Requirements Concerning Medicines Risk Communication Communication of actual and alleged risks associated to medicines: three different scenarios

IMI Standards

• A predefined set of teaching objectives, leading to defined learning outcomes
• Assessment of the students' achievement in accordance with the agreed learning outcomes of the training offered
• A system for collecting, assessing and addressing feedback from learners, teachers, technical / administrative staff and programme / course / module managers
• Availability of appropriate and regularly reviewed reference material (e.g. published articles, links, book chapters, scripts, etc)
• Defined and transparent admission criteria
• Quality assurance of teaching staff
• Regular review of the QA/QC process and demonstration that the training is further developed in light of this review
• The facilities, infrastructure, leadership and competences available for the support of student learning
• University accreditation OR a system for approving, monitoring and reviewing the training offered